Navigation Links
Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Date:8/31/2007

TOLEDO, Ohio, Aug. 31 /PRNewswire-FirstCall/ -- Manor Care, Inc. (NYSE: HCR) announced today that its Board of Directors has approved October 17, 2007 as the date for a special meeting of stockholders to vote on the proposed acquisition of Manor Care by an affiliate of global private equity firm The Carlyle Group and has approved September 10, 2007 as the record date for the meeting. On August 6, 2007, Manor Care filed a preliminary proxy statement in connection with the proposed transaction with the Securities and Exchange Commission. The proxy statement, once final, will be mailed together with a proxy card to Manor Care stockholders of record as of the record date. Manor Care expects the final proxy statement to be available shortly.

Manor Care, Inc., through its operating group HCR Manor Care, is a leading provider of short-term post-acute services and long-term care. The company's nearly 60,000 employees provide high-quality care for patients and residents through a network of more than 500 skilled nursing and rehabilitation centers, assisted living facilities, outpatient rehabilitation clinics, and hospice and home care agencies. The company operates primarily under the respected Heartland, ManorCare Health Services and Arden Courts names. Shares are traded on the New York Stock Exchange under the ticker symbol HCR.

Additional Information about the Merger and Where to Find It

In connection with this proposed merger of Manor Care, Inc. with MCHCR-CP Merger Sub Inc., an affiliate of The Carlyle Group, the company will file a proxy statement with the Securities and Exchange Commission ("SEC"). BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT FILED WITH THE SEC CAREFULLY AND IN ITS ENTIRETY WHEN IT BECOMES AVAILABLE BECAUSE IT WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. The final proxy statement will be mailed to the company's stockholders. In addition, stockholders will be able to obtain the proxy statement and all other relevant documents filed by the company with the SEC free of charge at the SEC's website at http://www.sec.gov or from Manor Care, Inc., Corporate Communications, P.O. Box 10086, Toledo, Ohio 43699, (419) 252-5500.

Participants in the Solicitation

The company and its directors, executive officers, and other members of management and employees may be deemed to be participants in the solicitation of proxies from the stockholders of the company in connection with the proposed transaction. Information about the company and its directors and executive officers, and their ownership of the company's securities, is set forth in the proxy statement for the 2007 Annual Meeting of Stockholders of the company, which was filed with the SEC on April 6, 2007, and the preliminary proxy statement for the special meeting to consider the proposed transaction filed with the SEC on August 6, 2007. Additional information regarding the interests of those persons, which interests may be different than those of the company's stockholders generally, may be obtained by reading the proxy statement when it becomes available.


'/>"/>
SOURCE Manor Care, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Child Health: Orphanage vs. Foster Care, A Study
2. The Costliest Flu Ever – This Bird-Flu Scare, Aint chicken feed
3. Bariatric Surgery: Medicare, Will Now Cough Up For ‘Throwing Weight
4. Adequate Foot Care, the Only Way to Prevent Amputation of Lower Limbs in Diabetics
5. Adult Heart Care, Cause of Heart ache in Europe.
6. PM announces a new health care order for India
7. PowderMed Announces Needle-Less Flu Vaccine
8. Ramdoss Announces Introduction of RCH-II
9. Britain Announces Third Transfusion Related Mad Cow Case
10. Tibet Announces the Dalai Lama’s Tour of South Americ
11. NHS announces further Cost cutting Measures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Presence Technology ... has been included by Gartner, Inc. in the Contact Center Infrastructure Magic Quadrant ... Center Infrastructure technologies, some of which include: Computer-telephony integration (CTI)/Web services interfaces, ...
(Date:5/31/2016)... ... 31, 2016 , ... St. Joseph Medical Center (SJMC) announced ... which enables physicians at SJMC’s two hospital campuses, downtown and in the Heights, ... the exchange. SJMC’s membership in the health information exchange underscores the hospital’s commitment ...
(Date:5/31/2016)... ... May 31, 2016 , ... The University of Tennessee Medical ... and the latest in Clinical Patient Pod (CPP) technologies provided through ... directly into the clinical workflow. These insights are empowering the more than 30 ...
(Date:5/31/2016)... ... 2016 , ... DDL, Inc. announced today it has expanded the scope of ... ISO 594-1 and ISO 594-2 testing for conical (Luer) fittings. , A conical ... medical devices (e.g. a syringe and hypodermic needle) that carry small volumes of fluids. ...
(Date:5/31/2016)... ... May 31, 2016 , ... Spartan Bioscience today introduced the ... and convenience. , The Cube is exceptionally small—it takes up the space of ... easily into any space, whether in a hospital, doctor’s office, or pharmacy. , ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 31, 2016 According to a ... (Scanners, Software), by Type (Human, Animal Pathology), by End ... Drug Discovery) - Global Forecasts to 2021", published by ... forecast period of 2016 to 2021. This market is ... USD 384.3 Million in 2016, at a CAGR of ...
(Date:5/31/2016)... 2016   Plexus Technology Group, LLC ... management systems (AIMS), is pleased to announce the ... President of Technology. In this new capacity, Mr. ... the company,s technological development. He will collaborate with ... the expansion of new products, product features and ...
(Date:5/31/2016)... BASEL, Switzerland , May 31, 2016 ... has announced the initiation of a first-in-human clinical trial ... class, fusion molecule - S101 is currently being developed ... phase 1 study is designed to evaluate the safety ... be conducted at several sites across the ...
Breaking Medicine Technology: